Vice President, Portfolio and Program Management jobs in United States
cer-icon
Apply on Employer Site
company-logo

Contineum Therapeutics · 2 weeks ago

Vice President, Portfolio and Program Management

Contineum Therapeutics is a growing biotech company focused on developing new therapies for NI&I. The Vice President of Portfolio & Program Management will provide strategic leadership and operational excellence, overseeing clinical development programs and ensuring timely execution in compliance with regulatory standards.

Pharmaceuticals

Responsibilities

Develop and maintain an integrated, data-driven portfolio strategy aligned with corporate vision and scientific priorities
Lead portfolio review processes, ensuring timely, evidence-based decision-making and clear resource allocation across programs
Evaluate and prioritize internal programs and external opportunities, including partnerships, licensing deals, and platform extensions
Conduct scenario planning, risk assessments, and investment trade-off analyses to guide strategic direction
Oversee or directly lead key development programs spanning discovery, preclinical, and clinical stages
Drive creation and execution of integrated, cross-functional program plans encompassing research, translational, clinical, regulatory, CMC, and commercial considerations
Ensure programs meet timelines, budgets, and milestones; actively identify risks, dependencies, and mitigation strategies
Maintain transparent reporting systems and dashboards for executive leadership, governance committees, and the board
Partner with Research, across Clinical Development functions, and with other internal teams to ensure alignment and operational excellence
Facilitate clear communication and decision-making across all program teams
Support readiness for key milestones such as IND submissions, clinical trial initiations, regulatory interactions, and strategic partnerships
Together with the CMO, establish and refine clinical development team and governance frameworks that enable efficient and high-quality development activities, clear decision-making structures, that facilitate clear communication and a documented alignment in R&D strategy
Build and mentor a high-performing PPM function tailored to the needs of a small, rapidly growing biotech
Implement best practices in project planning, resource management, and cross-functional communication
Champion a culture of accountability, transparency, and collaboration across the organization

Qualification

Clinical DevelopmentProject ManagementLeadershipRegulatory AffairsStrategic PlanningCross-functional Team LeadershipCommunication SkillsOrganizational Skills

Required

Advanced degree in a scientific or medical discipline relevant to inflammation, immunology, and/or fibrosis or to drug development (PhD, MD, PharmD strongly preferred)
15+ years of experience in biotech/pharma, including significant time leading development programs in inflammation, fibrosis, immunology, and/or neurosciences - experience specific to pulmonary fibrosis is viewed positively
Demonstrated success managing programs from Pre-IND, through Phase 2 and Phase 3 registrational trials; experience in early through or mid to late-stage clinical development is required
Excellent leadership, communication, and organizational skills, with the ability to operate effectively in a small, fast-paced biotech environment

Benefits

90% employer-covered benefits
Flexible PTO
A very generous holiday schedule that includes a week off in August and time off around the winter holidays
A well-stocked kitchen with snacks and beverages
Additional benefits include the opportunity for annual bonuses, stock options, an Employee Stock Purchase Program, and a 401(k) with an employer match
The comprehensive wellness program includes medical, dental, vision, and LTD coverage

Company

Contineum Therapeutics

twitter
company-logo
Contineum Therapeutics (Nasdaq: CTNM) is a clinical-stage biopharmaceutical company pioneering novel, oral small molecule therapies for NI&I indications with significant unmet need.

Funding

Current Stage
Growth Stage
Company data provided by crunchbase